Completion of isoniazid–rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness–implementation randomized trial
In this interim analysis, Adithya Cattamanchi and colleagues report their findings on 3HP patient acceptance and completion in a routine HIV care context.
South Africa United States San Francisco Universitatsklinikum Heidelberg Claudiam Denkinger University Of California
Source: plos.org